ALPRAZOLAM
- Product NDC
- 61919-862
- 11-digit product format
- 619190862
- Labeler code
- 61919
- Product ID
- 61919-862_87d379da-103c-c751-e053-2995a90a56de
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ALPRAZOLAM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA074909
- Marketing category
- ANDA
- Marketing start
- 2019-05-01
- Marketing end
- 0000-00-00
- Substance
- ALPRAZOLAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 61919-862 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 61919-862 | 61919-862-60 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074909-001 | ALPRAZOLAM | ALPRAZOLAM | 2MG | TABLET / ORAL | AB | 1998-03-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A074909-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074909-001 | ALPRAZOLAM | 2MG | TABLET / ORAL | AB | 1998-03-25 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074909-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | A-S Medication Solutions | 3c0cb60f-1c3a-48a6-ad16-f14351548412 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 7538d0d0-346e-4c3e-8f7a-c1cac8ec8ed3 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Sandoz Inc | d9b0e228-17cf-40d7-b62e-5050311c571c | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Bryant Ranch Prepack | b0000772-2514-45a2-a75d-1bbb13c29989 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | 074909 ANDA074909 |
| Alprazolam | ALPRAZOLAM | Proficient Rx LP | 717ce509-f92e-4ec1-a3c6-aeae54d56f4d | 2020-08-01 | Warnings, Adverse reactions | 074909 ANDA074909 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-862-60 | EA - Each | 61919-862 | 13286fbb-15d2-4d9f-ad3d-81dd34b5188e | 1 | 2019-06-19 |